United States · FDA National Drug Code directory
triple antibiotic
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-143_007b5d54-72af-4d4e-a893-c6a79396b9b3
- Product NDC
- 45802-143
- Form
- OINTMENT
- Composition / generic term
- bacitracin zinc, neomycin, polymyxin B
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20140520
- Source listing expiry
- 20261231
Source-listed ingredients
- BACITRACIN ZINC — 400 [USP'U]/g
- NEOMYCIN SULFATE — 3.5 mg/g
- POLYMYXIN B SULFATE — 5000 [USP'U]/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (45802-143-01) / 14 g in 1 TUBE · 45802-143-01
- 1 TUBE in 1 CARTON (45802-143-03) / 28 g in 1 TUBE · 45802-143-03
- 144 PACKET in 1 CARTON (45802-143-70) / .9 g in 1 PACKET (45802-143-00) · 45802-143-70
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →